A reduced dosing strategy can work for Alectinib in ALK rearranged non small cell lung cancer

• Danielle Benedict Sacdalan,
• Josephine Anne Lucero

Affiliations

Danielle Benedict Sacdalan

Institute of Medical Science, Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada; Corresponding author at: Princess Margaret Cancer Research Tower, MaRS building, 101 College Street, Rm 9-301, M5G 1L7, Toronto, ON, Canada.

Josephine Anne Lucero

Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada